Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Flamein, J. L. Delaunay, C. Wolf, A. Lamaziere, M. Maurice, A. Clement, R. Epaud, L. Guillot (Paris, France). Phospholipids qualitative analysis: A new diagnostic tool to characterize ABCA3-Associated disease and guide genetic analysis. Eur Respir J 2010; 36: Suppl. 54, 5225

Member's Comments

No comment yet.

Related content which might interest you: COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease Source: Annual Congress 2010 - Scientific Year in Review Year: 2010 Using qualitative methods to explore the implementation of diagnostics in primary care Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course Year: 2019 Quantitative proteomic analysis: methods and applications Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Benchtop NMR-based metabolomic analysis as a diagnostic tool for tuberculosis in clinical urine samples Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Some current challenges in statistical methods to illuminate disease genetics Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Clinical COPD phenotypes: a novel approach using principal component and cluster analyses Source: Eur Respir J 2010; 36: 531-539 Year: 2010 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 A new statistical diagnostic tool for respiratory diseases Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 A multi-omics data integration approach to identify a predictive molecular signature of CLAD Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Metabolomic analyses reveal new stage-specific features of COVID-19 Source: Eur Respir J, 59 (2) 2100284; 10.1183/13993003.00284-2021 Year: 2022 Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016 Critical analysis of diagnostic techniques Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia Year: 2003